A K Mitra
Overview
Explore the profile of A K Mitra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
214
Citations
2099
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chauvin M, Meinsohn M, Dasari S, May P, Iyer S, Nguyen N, et al.
Cell Rep
. 2023 Jul;
42(7):112730.
PMID: 37453057
Cancer-associated mesothelial cells (CAMCs) in the tumor microenvironment are thought to promote growth and immune evasion. We find that, in mouse and human ovarian tumors, cancer cells express anti-Müllerian hormone...
2.
Lepore R, Kryshtafovych A, Alahuhta M, Veraszto H, Bomble Y, Bufton J, et al.
Proteins
. 2019 Aug;
87(12):1037-1057.
PMID: 31442339
The functional and biological significance of selected CASP13 targets are described by the authors of the structures. The structural biologists discuss the most interesting structural features of the target proteins...
3.
Mitra A, Harding T, Mukherjee U, Jang J, Li Y, HongZheng R, et al.
Blood Cancer J
. 2017 Jul;
7(6):e581.
PMID: 28665416
Extensive interindividual variation in response to chemotherapy is a major stumbling block in achieving desirable efficacy in the treatment of cancers, including multiple myeloma (MM). In this study, our goal...
4.
Bhat P, Mitra A, Anand A
Med J Armed Forces India
. 2016 Jul;
66(1):88-9.
PMID: 27365717
No abstract available.
5.
Hu C, ABraham A, Mitra A, Griffiths S
Public Health
. 2015 Dec;
136:196-9.
PMID: 26715320
No abstract available.
6.
Mitra A, Mukherjee U, Harding T, Jang J, Stessman H, Li Y, et al.
Leukemia
. 2015 Dec;
30(5):1094-102.
PMID: 26710886
Multiple myeloma (MM) is characterized by significant genetic diversity at subclonal levels that have a defining role in the heterogeneity of tumor progression, clinical aggressiveness and drug sensitivity. Although genome...
7.
Kohlhapp F, Mitra A, Lengyel E, Peter M
Oncogene
. 2015 Apr;
34(48):5857-68.
PMID: 25867073
Cancer cells grow in an environment comprised of multiple components that support tumor growth and contribute to therapy resistance. Major cell types in the tumor microenvironment are fibroblasts, endothelial cells...
8.
Mitra A, Chiang C, Tiwari P, Tomar S, Watters K, Peter M, et al.
Oncogene
. 2015 Mar;
34(48):5923-32.
PMID: 25798837
The cross-talk between ovarian cancer (OvCa) cells and the metastatic microenvironment is an essential determinant of successful colonization. MicroRNAs (miRNAs) have several critical roles during metastasis; however, the role of...
9.
Ly K, Bartho J, Eicher T, Pos K, Mitra A
FEBS Lett
. 2014 Dec;
588(24):4776-83.
PMID: 25451234
The central component AcrB of the Escherichia coli drug efflux complex AcrA-AcrB-TolC has been extensively investigated by X-ray crystallography of detergent-protein 3-D crystals. In these crystals, AcrB packs as trimers...
10.
Vadlapatla R, Vadlapudi A, Pal D, Mukherji M, Mitra A
Eye (Lond)
. 2013 Nov;
28(1):93-101.
PMID: 24202050
Purpose: Retinal hypoxia-mediated activation of the hypoxia-inducible factor (HIF pathway) leading to angiogenesis is a major signaling mechanism underlying a number of sight-threatening diseases. Inhibiting this signaling mechanism with an...